(Q24240463)

https://api.crossref.org/works/10.1002%2F14651858.CD007893.PUB2

Cyclosporin in rheumatoid arthritis: a double blind, placebo controlled study in 52 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007893.PUB2

Cyclosporine for plaque-type psoriasis. Results of a multidose, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007893.PUB2

Double-blind, placebo-controlled study of cyclosporin A as a corticosteroid-sparing agent in corticosteroid-dependent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007893.PUB2

Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007893.PUB2

Low-dose cyclosporin versus placebo in patients with rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007893.PUB2

Effects of Isradipine on Renal Function in Cydosporin-Treated Renal Transplanted Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007893.PUB2

Plasma interleukin-2 and a soluble/shed interleukin-2 receptor in serum of patients with Crohn's disease. Effect of cyclosporin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007893.PUB2

Placebo-controlled trial of cyclosporin-A in HIV-1 disease: implications for solid organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007893.PUB2

Cyclosporin A in severe, therapy-resistant atopic dermatitis: report of an international workshop, April 1993.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007893.PUB2

Effect of cyclosporin A (CyA) on the immunopathological lesion of the labial minor salivary glands from patients with Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007893.PUB2

Cyclosporin in the treatment of severe chronic idiopathic uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007893.PUB2

Cyclosporin A (CyA) in primary Sjögren's syndrome: a double blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007893.PUB2

Randomized double-blind study of cyclosporin in chronic 'idiopathic' urticaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007893.PUB2

Calcium channel blockade and preservation of renal graft function in cyclosporine-treated recipients: a prospective randomized placebo-controlled 2-year study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007893.PUB2

Effect of felodipine on renal haemodynamics and tubular sodium handling after single-dose cyclosporin infusion in renal transplant recipients treated with azathioprine and prednisolone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007893.PUB2

Brain metabolic and hemodynamic effects of cyclosporin A after human severe traumatic brain injury: a microdialysis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007893.PUB2

A randomized, double-blind, multicenter, controlled clinical trial of cyclosporine plus chloroquine vs. cyclosporine plus placebo in early-onset rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007893.PUB2

Multicenter, randomized study of the effectiveness of basiliximab in avoiding addition of steroids to cyclosporine a monotherapy in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007893.PUB2

Randomised double blind controlled trial of cyclosporin in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007893.PUB2

Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis. A randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007893.PUB2

Ulcerative colitis disease activity following treatment of associated primary sclerosing cholangitis with cyclosporin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007893.PUB2

Effect of cyclosporin A on the allergen-induced late asthmatic reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007893.PUB2

Cyclosporin treatment for rheumatoid arthritis: a placebo controlled, double blind, multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007893.PUB2

Induction of Interleukin 2 Messenger RNA Inhibited by Cyclosporin A

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007893.PUB2

Cyclosporine in severe psoriasis. Results of a meta-analysis in 579 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007893.PUB2

Blood pressure lowering efficacy of angiotensin receptor blockers for primary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007893.PUB2

Factors affecting blood pressure variability: lessons learned from two systematic reviews of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007893.PUB2

Double-blind placebo-controlled study of long-term low-dose cyclosporin in the treatment of palmoplantar pustulosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007893.PUB2

Sequential effects of cyclosporine therapy on blood pressure, renal function and neurohormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007893.PUB2

Low-Dose Cyclosporine for the Treatment of Crohn's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007893.PUB2

Cyclosporine in the treatment of palmoplantar pustulosis. A randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007893.PUB2

7 January 2021

A double-blind study of the effectiveness of cyclosporine in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007893.PUB2

7 January 2021

Efficacy and toxicity of cyclosporine in chronic progressive multiple sclerosis: a randomized, double-blinded, placebo-controlled clinical trial. The Multiple Sclerosis Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007893.PUB2

7 January 2021

Follow-up of cyclosporin A treatment in type 1 (insulin-dependent) diabetes mellitus: lack of long-term effects

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007893.PUB2

7 January 2021

Effect of cyclosporin on serum creatinine in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007893.PUB2

7 January 2021

Effect of cyclosporine A on circulating immune complexes in IgA nephropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007893.PUB2

7 January 2021

Pharmacokinetic interaction between cyclosporine and the dihydropyridine calcium antagonist felodipine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007893.PUB2

7 January 2021

Cyclosporin A treatment in primary biliary cirrhosis: results of a long-term placebo controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007893.PUB2

7 January 2021

European trial of cyclosporine in chronic active Crohn's disease: a 12-month study. The European Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007893.PUB2

7 January 2021

Prevention of renal dysfunction and hypertension by amlodipine after heart transplant

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007893.PUB2

7 January 2021

Cyclosporine in chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007893.PUB2

7 January 2021

Efficacy of ISA247 in plaque psoriasis: a randomised, multicentre, double-blind, placebo-controlled phase III study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007893.PUB2

7 January 2021

A controlled trial of cyclosporine in patients with progressive membranous nephropathy. Canadian Glomerulonephritis Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007893.PUB2

7 January 2021

Renal hemodynamics and pharmacokinetics of bosentan with and without cyclosporine A

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007893.PUB2

7 January 2021

A controlled trial of cyclosporine in the treatment of primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007893.PUB2

7 January 2021

Adding low-dose cyclosporin A to parenteral gold therapy in rheumatoid arthritis: a double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007893.PUB2

7 January 2021

Serial changes in blood pressure, renal function, endothelin and lipoprotein (a) during the first 9 days of cyclosporin therapy in males

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007893.PUB2

7 January 2021

Cyclosporine-induced hypertension and decline in renal function in healthy volunteers

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007893.PUB2

7 January 2021

Induction of contraction in isolated rat aorta by cyclosporine.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007893.PUB2

7 January 2021

Isradipine for the prevention of cyclosporine-induced hypertension in allogeneic bone marrow transplant recipients: a randomized, double-blind study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007893.PUB2

7 January 2021

Low-dose cyclosporin A in severe psoriasis. A double-blind study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007893.PUB2

7 January 2021

Renal function and blood pressure in psoriatic patients treated with cyclosporin A

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007893.PUB2

7 January 2021

Maintenance treatment with cyclosporin in atopic eczema

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007893.PUB2

7 January 2021

Cyclosporin in atopic dermatitis: a multicentre placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007893.PUB2

7 January 2021

Cyclosporin treatment of IgA nephropathy: a short term controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007893.PUB2

7 January 2021

Treatment of steroid-dependent bronchial asthma with cyclosporin

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007893.PUB2

7 January 2021

10.1002/14651858.CD007893.PUB2

Identifiers

DOI

0 references

Fatcat ID

release_3ufcvxevpfephgz7pzrcydntba

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3ufcvxevpfephgz7pzrcydntba

24 November 2022